A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
How Designers Create Welcoming Senior Care Communities
Data-Driven Decisions: How Analytics Are Shaping Healthcare Facility Planning
UC Health Opens Expanded Freeman Center for Developmental Disabilities
Upward Mobility: Market Forces Drive Hospitals Higher
Georgia Hospital Bomb Hoaxes Highlight Need for Healthcare–Police Partnerships